RANIBIZUMAB BS INTRAVITREAL INJECTION KIT 10mg/mL "SENJU" [age-related macular degeneration associated with subfoveal choroidal neovascularization] (ラニビズマブBS硝子体内注射用キット10mg/mL「センジュ」［中心窩下脈絡膜新生血管を伴う加齢黄斑変性］)

Country: Japan

Language: English

Source: すりの適正使用協議会 RAD-AR Council, Japan

Active ingredient:

Ranibizumab(genetical recombination)[ranibizumab biosimilar 1]

Available from:

SENJU PHARMACEUTICAL CO.,LTD.

INN (International Name):

Ranibizumab(genetical recombination)[ranibizumab biosimilar 1]

Pharmaceutical form:

injection

Patient Information leaflet

Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 02/2023
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
RANIBIZUMAB BS INTRAVITREAL INJECTION
KIT 10MG/ML "SENJU" [AGE-RELATED MACULAR
DEGENERATION ASSOCIATED WITH SUBFOVEAL
CHOROIDAL NEOVASCULARIZATION]
ACTIVE INGREDIENT:
Ranibizumab(genetical recombination)[ranibizumab
biosimilar 1]
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine inhibits vascular endothelial growth factor (VEGF) which
is involved in formation
and growth of choroidal neovascularization and causes atrophy/loss of
choroidal
neovascularization. As a result, it improves failing vision.
It is usually used to treat age-related macular degeneration
associated with subfoveal
choroidal neovascularization.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have: ocular/periocular infections or suspected of them,
intraocular inflammation, a
history of stroke or transient ischemic attack.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         

to be written by a healthcare
professional
))
・In general, administer by intraocular (intravitreal) injection once
a month for the 3